Amniotic membrane in the treatment of defects in diabetic patients
Close
Articolul precedent
Articolul urmator
350 0
SM ISO690:2012
MIHALUŢA, Viorica, STOIAN, Alina, FEGHIU, Leonid, FORTUNA, Elvira. Amniotic membrane in the treatment of defects in diabetic patients. In: MedEspera: International Medical Congress for Students and Young Doctors, Ed. 8th edition, 24-26 septembrie 2020, Chişinău. Chisinau, Republic of Moldova: 2020, 8, p. 116. ISBN 978-9975-151-11-5.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
MedEspera
8, 2020
Congresul "International Medical Congress for Students and Young Doctors"
8th edition, Chişinău, Moldova, 24-26 septembrie 2020

Amniotic membrane in the treatment of defects in diabetic patients


Pag. 116-116

Mihaluţa Viorica, Stoian Alina, Feghiu Leonid, Fortuna Elvira
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 22 decembrie 2020


Rezumat

Introduction. One of the most current and complicated aspects of plastic surgery is the treatment of defects in diabetic patients. The inefficiency of the conservative treatment and the the surgical interventions with the sacrifice of other healthy tissues requires the use of new methods of treatment Aim of the study. Optimizating the local regeneration in patients with peripheral circulatory disorders using biological materials obtained through tissue engineering Materials and methods. We initiated a study in a group of 5 patients with peripheral circulatory disorders with chronic non-healing wounds (> 30 day duration). The pacients were selected to evaluate the performance, safety and handling properties of dehydrated human amnion / chorion membrane allograft. All five patients received only one application of dehydrated human amniotic membrane and there were no adverse effects. Results. Was obtained optimization of local regeneration in patients with peripheral circulatory disorders by tissue engineering methods Conclusions. The research in this direction will establish the perfect combination of support material for cells and growth factors, for a faster and qualitative epithelialization, thus facilitating epithelialization of ulcers and wounds in patients with circulatory disorders

Cuvinte-cheie
diabetes, wounds, tissue engineering